Erytech Pharma - Spon ADR (PHXM)
Institutional ownership reported to the SEC as of Q1 2024, across 22 quarters.
1
Reporting holders
$1
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Asset Dedication, LLC | $1 | 400 | 0.00% | 3q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2024 | 1 | $1 | 400 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 1 | $2 | 400 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 3 | $1.6K | 708 | 3 | 0 | 0 | 0.0% |
| Q2 2023 | 8 | $96.3K | 131,763 | 2 | 1 | 2 | 0.3% |
| Q1 2023 | 5 | $297.9K | 294,644 | 0 | 1 | 3 | 0.2% |
| Q4 2022 | 6 | $225.9K | 683,490 | 1 | 2 | 1 | 0.0% |
| Q3 2022 | 9 | $784.0K | 1,485,082 | 3 | 0 | 3 | 0.0% |
| Q2 2022 | 7 | $1.7M | 1,503,746 | 3 | 2 | 0 | 5.0% |
| Q1 2022 | 6 | $6.7M | 3,351,792 | 0 | 1 | 4 | 11.2% |
| Q4 2021 | 9 | $11.2M | 4,244,033 | 5 | 4 | 0 | 11.1% |
| Q3 2021 | 10 | $11.6M | 2,011,390 | 6 | 0 | 1 | 0.0% |
| Q2 2021 | 4 | $9.4M | 1,946,556 | 1 | 1 | 0 | 0.0% |
| Q1 2021 | 3 | $8.9M | 1,261,343 | 1 | 0 | 0 | 0.0% |
| Q4 2020 | 4 | $12.0M | 1,260,926 | 1 | 0 | 1 | 0.0% |
| Q3 2020 | 3 | $7.8M | 1,265,342 | 0 | 0 | 0 | 0.0% |
| Q2 2020 | 4 | $11.4M | 1,298,293 | 0 | 0 | 1 | 0.0% |
| Q1 2020 | 4 | $7.1M | 1,335,342 | 0 | 0 | 0 | 0.0% |
| Q4 2019 | 4 | $9.8M | 1,335,342 | 0 | 0 | 1 | 0.0% |
| Q3 2019 | 5 | $6.3M | 1,455,419 | 0 | 0 | 2 | 0.0% |
| Q2 2019 | 5 | $10.4M | 1,458,619 | 0 | 0 | 2 | 0.0% |
| Q1 2019 | 5 | $11.1M | 1,462,682 | 0 | 0 | 1 | 0.0% |
| Q4 2018 | 5 | $9.9M | 1,463,682 | 0 | 0 | 0 | 0.0% |